0001721484-24-000004.txt : 20240723 0001721484-24-000004.hdr.sgml : 20240723 20240723134135 ACCESSION NUMBER: 0001721484-24-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240723 DATE AS OF CHANGE: 20240723 EFFECTIVENESS DATE: 20240723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Longeveron Inc. CENTRAL INDEX KEY: 0001721484 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472174146 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-519504 FILM NUMBER: 241133793 BUSINESS ADDRESS: STREET 1: 1951 NW 7TH AVENUE STREET 2: SUITE 520 CITY: MIAMI STATE: FL ZIP: 33136 BUSINESS PHONE: 305-302-7158 MAIL ADDRESS: STREET 1: 1951 NW 7TH AVENUE STREET 2: SUITE 520 CITY: MIAMI STATE: FL ZIP: 33136 FORMER COMPANY: FORMER CONFORMED NAME: LONGEVERON LLC DATE OF NAME CHANGE: 20171101 D 1 primary_doc.xml X0708 D LIVE 0001721484 Longeveron Inc. 1951 NW 7TH AVENUE SUITE 520 MIAMI FL FLORIDA 33136 305-909-0840 DELAWARE LONGEVERON LLC Corporation true Wa'el Hashad 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Executive Officer Director Joshua M. Hare 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Executive Officer Director Lisa A. Locklear 1951 NW 7TH Avenue Suite 530 Miami FL FLORIDA 33136 Executive Officer Nataliya Agafonova 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Executive Officer Paul Lehr 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Executive Officer Neil E. Hare 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Rock Soffer 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Ursula Ungaro 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Khoso Baluch 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Richard Kender 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Neha J. Motwani 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Roger Joseph Hajjar 1951 NW 7TH Avenue Suite 520 Miami FL FLORIDA 33136 Director Biotechnology Decline to Disclose 06b false 2024-07-19 false true true false 0 H.C. Wainwright & Co., LLC 375 Craig Schwabe 3137679 430 Park Avenue 4TH Floor New York NY NEW YORK 10022 NY NEW YORK false H.C. Wainwright & Co., LLC 375 Charles Worthman 5160596 430 Park Avenue 4TH Floor New York NY NEW YORK 10022 NY NEW YORK false H.C. Wainwright & Co., LLC 375 Michael Vasinkevich 2843810 430 Park Avenue 4TH Floor New York NY NEW YORK 10022 NY NEW YORK false H.C. Wainwright & Co., LLC 375 Noam Rubinstein 4070245 430 Park Avenue 4TH Floor New York NY NEW YORK 10022 NY NEW YORK false 9508010 0 9508010 The total offering amount reflects the purchase price of warrants and the exercise price due to the Company assuming cash exercise of all warrants issued to the accredited investors and placement agent in the private placement under Rule 506(b). false 3 630000 true 0 In connection with the registered direct offering, the placement agent received $630,000.33, and warrants to purchase up to 156,522 shares of Common Stock exercisable at $5.0313 per share, among other items. 0 false Longeveron Inc. /s/ Wa'el Hashad Wa'el Hashad Chief Executive Officer 2024-07-23